American Vietnamese Biotech Incorporation (HNX:AMV)

Vietnam flag Vietnam · Delayed Price · Currency is VND
1,800.00
0.00 (0.00%)
At close: Apr 6, 2026
Market Cap235.99B -53.8%
Revenue (ttm)154.07B -50.4%
Net Income-53.05B
EPS-405.00
Shares Out131.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume166,974
Average Volume559,161
Open1,800.00
Previous Close1,800.00
Day's Range1,700.00 - 1,800.00
52-Week Range1,700.00 - 2,800.00
Beta0.93
RSI44.29
Earnings DateMay 5, 2026

About HNX:AMV

American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical diagnostic biological products in Vietnam. The company develops centralized testing centers; and provides medical machinery and equipment, and testing chemicals. It also offers sterilizers, drug labeling machines, medical image disc recorders, medical dry films, medical dry film printers, and digital radiology systems; lizer infrared therapy machines; infusion pumps and electric injection pumps; automatic molecular biology testing machines and automati... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 103
Stock Exchange Hanoi Stock Exchange
Ticker Symbol AMV
Full Company Profile

Financial Performance

In 2025, HNX:AMV's revenue was 154.07 billion, a decrease of -50.36% compared to the previous year's 310.35 billion. Losses were -53.05 billion, 374.0% more than in 2024.

Financial Statements